| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |